ACHV · Achieve Life Sciences, Inc.
$6.50
+0.26 (+4.17%)
At close · Jul 21
Market Cap
$667.28M
Shares
102.66M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$0
FY2019
Net Income
-$54.65M
-37.2%
FY2025
Diluted EPS
-$1.25
-0.8%
FY2025
Operating Cash Flow
-$49.47M
-66.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | $0 | $0 | — | — | — | — | — | — | — | |
| $26.42M | — | $22.82M | $15.81M | $30.08M | $23.97M | $6.88M | $9.67M | $5.87M | $3.1M | $14.79M | $25.11M | $46.22M | $55.32M | $39.95M | $21.55M | |
| $25.92M | — | $16.25M | $11.44M | $10.72M | $9.13M | $7.87M | $6.85M | $6.95M | $3.53M | $8.93M | $11.81M | $10.63M | $9.89M | $7.79M | $6.23M | |
| $200K | $200K | $200K | $200K | $200K | $200K | $200K | $200K | $200K | $200K | — | — | — | — | — | — | |
| — | $228K | $229K | $228K | $236K | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | -$1.66M | — | |
| — | — | — | — | — | — | — | — | — | — | — | $36.91M | — | — | — | — | |
| $52.45M | $54.88M | $39.07M | $27.25M | $40.8M | $33.09M | $14.75M | $16.53M | $12.81M | $6.63M | $26.25M | $9.5M | $56.58M | $65.21M | $46.08M | $27.78M | |
| $908K | $819K | $2.18M | $2.85M | $1.79M | — | — | — | — | — | — | — | — | — | — | — | |
| $1.47M | $1.5M | $2.36M | $825K | $199K | $17K | $69K | $170K | $171K | $21K | $203K | $119K | $35K | $150K | $292K | $220K | |
| $460K | $232K | -$758K | -$2.57M | -$1.55M | -$58K | $20K | $133K | $126K | -$7M | $1.06M | $1.95M | $3.23M | $3.48M | $4.89M | $7.61M | |
| — | -$54.65M | -$39.83M | -$29.82M | -$42.35M | -$33.15M | — | -$16.4M | -$12.69M | -$13.63M | — | — | — | — | -$21.1M | -$14.67M | |
| — | — | — | — | — | — | — | — | — | — | $0 | $0 | $0 | — | -$3M | -$3M | |
| -$51.99M | -$54.65M | -$39.83M | -$29.82M | -$42.35M | -$33.15M | -$14.73M | -$16.4M | -$12.69M | -$10.58M | -$20.13M | -$16.8M | -$26.24M | -$31.85M | -$21.1M | -$14.67M | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -$14.67M | |
| -$51.99M | -$54.67M | -$39.8M | — | — | — | — | -$16.4M | -$12.69M | -$10.58M | -$20.12M | -$16.79M | -$26.26M | -$31.84M | -$21.1M | — | |
| USD/shares | — | -$1.25 | -$1.24 | -$1.50 | -$4.00 | — | — | — | — | — | — | — | — | — | -$19.60 | — |
| USD/shares | — | -$1.25 | -$1.24 | -$1.50 | -$4.00 | — | — | — | — | — | — | — | — | — | -$19.60 | — |
| shares | — | 43.59M | 32.07M | 19.83M | 10.59M | 8.12M | 2.72M | 412.32K | 175.51K | 239.72K | 1.5M | 1.31M | 904.94K | 734.17K | 676.14K | — |
| shares | — | 43.59M | 32.07M | 19.83M | 10.59M | 8.12M | 2.72M | 412.32K | 175.51K | 239.72K | 1.5M | 1.31M | 904.94K | 734.17K | 676.14K | — |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Biotechnology median 8.68×
EV/EBIT
—
Biotechnology median 26.45×
P/E (TTM)
—
Biotechnology median 7.21×